A to Z / Approved medicine
Teduglutide
Also known as Gattex, Revestive, GLP-2 analogue.
Best known for The GLP-2 analogue that grows intestinal lining
Evidence★★★★★
Safety dataWell characterised
Route Daily subcutaneous injection
United StatesFDA approved
AustraliaSchedule 4: prescription only
as at 16 September 2026
What it is and what it does
Teduglutide is an approved analogue of GLP-2, a lesser-known relative of GLP-1 that regulates intestinal growth rather than appetite. It is used to treat short bowel syndrome in people dependent on intravenous nutrition.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Semaglutide, Linaclotide, Larazotide
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Teduglutide. It is not medical advice and not a recommendation to use it.